Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 16064

Sacramento, CA 95821


Study Summary:

A randomized, double-blind, parallel-group, vehicle-controlled, multicenter study comparing Imiquimod Cream 3.75% (Teva Pharmaceuticals, Inc.) to Zyclara ® (Imiquimod) Cream 3.75% (Medicis Pharmaceuticals,Inc) in the treatment of Actinic Keratosis of the face or balding scalp.


Qualified Participants Must:

• 18 years or older
• Have Actinic Keratosis of the face or balding scalp


Qualified Participants May Receive:

Compensation of $125 for completing study and one of the following:

  • Imiquimod Cream 3.75%
  • Zyclara ® Cream (Imiquimod 3.75%)
  • Vehicle Cream (inactive medicine also known as Placebo)


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.